Go Deep
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,439 | -0.3 | 1.56 | 1.20 | 35.26 |
| Oct 2026 | 22,493 | -0.3 | 1.50 | 1.20 | 33.66 |
| Oct 2026 | 22,241 | -0.4 | 1.80 | 1.20 | 40.55 |
| Oct 2026 | 22,078 | -0.4 | 2.00 | 1.20 | 44.88 |
| Oct 2026 | 22,091 | -0.4 | 1.98 | 1.20 | 44.56 |
| Oct 2026 | 22,109 | -0.4 | 1.96 | 1.20 | 44.09 |
| Oct 2026 | 22,279 | -0.3 | 1.76 | 1.20 | 39.35 |
| Oct 2026 | 22,315 | -0.3 | 1.71 | 1.20 | 38.29 |
Neumora Therapeutics, Inc. Quarterly Results
Quarterly data isn't available for this company right now.
Neumora Therapeutics, Inc. Revenue & Profit
Annual financial data isn't available for this company right now.
Neumora Therapeutics, Inc. Balance Sheet
Balance sheet data isn't available for this company right now.
Owes vs Owns
Neumora Therapeutics, Inc. owed $0.64 for every $1 it owned in Jun 2026, down from $2.05 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.64× | 0.46× | 0.09× | 0.05× | 2.05× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Neumora Therapeutics, Inc. Cash Flow
Cash flow data isn't available for this company right now.